tDCS + Cognitive Training for Fetal Alcohol Spectrum Disorders
Trial Summary
The trial information does not specify whether participants need to stop taking their current medications.
Research shows that combining transcranial direct current stimulation (tDCS) with cognitive training can improve brain function and outcomes in conditions with brain development issues, like Fetal Alcohol Spectrum Disorders. Studies in alcohol dependence have shown that tDCS can enhance brain activity and reduce cravings, suggesting it might help improve cognitive functions in FASD as well.
12345Research shows that transcranial direct current stimulation (tDCS) is generally safe for humans, including children and adults. Studies report that tDCS is well-tolerated with no serious side effects, such as seizures or loss of consciousness, and only minor discomfort during sessions.
13467This treatment is unique because it combines transcranial direct current stimulation (tDCS), a noninvasive brain stimulation technique that enhances brain plasticity, with cognitive training exercises. This combination aims to improve brain function more effectively than cognitive training alone, which is the most commonly studied treatment for executive deficits in Fetal Alcohol Spectrum Disorders.
1891011Eligibility Criteria
This trial is for children and teens aged 8-17 with Fetal Alcohol Spectrum Disorders (FASD) due to heavy prenatal alcohol exposure. They need a parent or guardian to consent. It's not for those with substance abuse, other developmental disorders, serious psychiatric conditions affecting the brain, very low birthweight, or who can't have MRI or tDCS.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Baseline visit with cognitive testing
Treatment
5 sessions of cognitive training with tDCS (active or sham)
Follow-up
Participants are monitored for changes in cognitive performance
Participant Groups
Active tDCS is already approved in United Kingdom, Brazil for the following indications:
- Depression
- Depression